Sangroongruangsri, S., Kittrongsiri, K., Charatcharoenwitthaya, P., Sobhonslidsuk, A., Chaikledkaew, U., & Hospital, S. (2022). Cost-utility analysis of vasoconstrictors plus albumin in the treatment of thai patients with type 1 hepatorenal syndrome.

Sangroongruangsri, Sermsiri, Kankamon Kittrongsiri, Phunchai Charatcharoenwitthaya, Abhasnee Sobhonslidsuk, Usa Chaikledkaew, and Siriraj Hospital. Cost-utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients With Type 1 Hepatorenal Syndrome. 2022.

Sangroongruangsri, Sermsiri, et al. Cost-utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients With Type 1 Hepatorenal Syndrome. 2022.